dulaglutide to semaglutide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are transitioning from semaglutide to tirzepatide

Patent protection typically prevents generic competition for many years after a drug's initial approval

A narrative review of STAT proteins in diabetic retinopathy: from mechanisms to therapeutic prospects

Blue Cross Blue Shield evaluates eligibility for weight loss surgery based on a combination of factors, including the severity of obesity, the presence of obesity-related comorbidities, and the failure of traditional weight loss methods

Meanwhile, decreased values of FBG during fasting revealed no statistical difference between the LC group and CT group (LC vs

"Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis"